+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development

Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development

Journal of Immunology 135(1): 180-184

Ontogenic development and the lymphokine responsiveness of human NK cell activity against K562 target cells in peripheral blood lymphocytes were evaluated in fetuses, premature infants, and term neonates by using a 4-hr 51Cr-release assay. Basal NK activity and NK boosting by lymphokines were comparatively assayed after an 18-hr incubation with medium alone, recombinant human IFN-gamma (1000 U/ml), and recombinant human IL 2 (25 U/ml), respectively. Lymphocytes from 20-wk-old fetuses lacked NK cell activity even after the pretreatment with IFN-gamma. Low, but significant levels of NK activity and NK boosting by IFN-gamma were observed in premature infants after 27 wk of gestation, with a progressive intrauterine maturation of these activities. Both basal NK activity and NK boosting by IFN-gamma in term neonates were still lower than those of adult controls. The grade of NK boosting by IFN-gamma appeared to depend on the development of basal NK activity. Contrary to IFN-gamma, IL 2 could induce marked NK activity even in 20-wk-old fetuses who lacked both basal and IFN-gamma inducible NK activities. NK boosting by IL 2 was much more efficient than that by IFN-gamma at any period of human life. The facts that IL 2-induced NK boosting could occur without any appreciable production of IFN-gamma in neonatal lymphocytes, and that ample neutralizing doses of anti-IFN-gamma antibody hardly suppressed IL 2-mediated NK boosting even in adult lymphocytes, indicated that the effect of IL 2 on NK boosting might be independent of IFN-gamma production. On the basis of the ontogenic differences in the development of the lymphokine responsiveness of NK cell activity and on the different NK boosting mechanisms of these lymphokines it was suggested that so-called human "pre-NK cells" might be divided into IFN-gamma sensitive and IL 2-sensitive cells. Whether these cell populations belong to different cell lineages or different maturation stages of the same cell line, however, remains unsettled.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 039825524

Download citation: RISBibTeXText

PMID: 3923100

Related references

Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon alpha or gamma, human recombinant interleukin-2 and indomethacin. International Journal of Immunopharmacology 10(8): 907-911, 1988

Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood. Journal of Immunology 135(4): 2351-2356, 1985

Recombinant interleukin 4 ril 4 stimulates a cell population from human peripheral blood to inhibit the development of lymphokine activated killer lak activity. Lymphokine Research 7(3): 297, 1988

Characterization of human interferon-gamma and human interleukin-2 from recombinant mammalian cell lines and peripheral blood lymphocytes. Lymphokine and Cytokine Research 10(3): 213-218, 1991

Interaction of recombinant interferons with recombinant interleukin 2 differential effects of natural killer cell activity and interleukin 2 activated killer cells. International Journal of Cancer 37(5): 787-793, 1986

The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells. Japanese Journal of Cancer Research 76(7): 608-617, 1985

Interleukin 2 and interferon-gamma are not sufficient to induce natural killer-like activity in human T cell clones. European Journal of Immunology 14(12): 1137-1141, 1984

Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia iv. interleukin 1 deficiency gamma interferon deficiency and the restorative effects of short term culture in the presence of interleukin 2 on natural killer cytotoxicity natural killer target binding and production of natural killer cytotoxic factor. Natural Immunity and Cell Growth Regulation 10(2): 57-70, 1991

In vitro enhancement of cytotoxicity of human peripheral blood lymphocytes with recombinant interleukin 2 and an interferon mixture (alpha + beta + gamma) against human colon carcinoma cell line SW1116. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3419-3426, 1986

Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. Journal of Immunology 136(6): 2176-2180, 1986

Decrease of lymphokine (interleukin-2)-activated killer activity in peripheral blood after administration of natural interferon-gamma. Japanese Journal of Clinical Oncology 20(4): 356-363, 1990

Effects of recombinant human interferon gamma met gln form on expression of fc receptor and ia like antigen on human peripheral monocytes and lymphocytes a comparative study with natural human interferon alpha and beta. Chemical & Pharmaceutical Bulletin 35(1): 335-343, 1987

Effects of recombinant human interferon-gamma (Met-Gln form) on expression of Fc receptor and Ia-like antigen on human peripheral monocytes and lymphocytes : A comparative study with natural human interferon-alpha and-beta. Chemical & Pharmaceutical Bulletin 35(1): 335-343, 1987

Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity. Clinical and Experimental Immunology 70(2): 354-363, 1987

Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12. Journal of Infectious Diseases 172(4): 1023-1027, 1995